scispace - formally typeset
Search or ask a question
Posted Content•DOI•

NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells and suppresses PDAC initiation

Isidoro Cobo, Sumit Paliwal, Júlia Melià-Alomà1, Ariadna Torres1, Jaime Martínez-Villarreal, Fernando García, Irene Millán, Natalia del Pozo, Joo-Cheol Park2, Raymond J. MacDonald3, Javier Munoz, Francisco X. Real1 •
Pompeu Fabra University1, Seoul National University2, University of Texas Southwestern Medical Center3
09 Aug 2021-bioRxiv (Cold Spring Harbor Laboratory)-
TL;DR: In this paper, NFIC binding sites are found at very short distances from NR5A2-bound genomic regions and both proteins co-occur in the same complex and NFIC dampens the ER stress program through its binding to ER stress gene promoters and is required for complete resolution of Tunicamycin-mediated ER stress.
Abstract: Tissue-specific differentiation is driven by specialized transcriptional networks. Pancreatic acinar cells crucially rely on the PTF1 complex, and on additional transcription factors, to deploy their transcriptional program. Here, we identify NFIC as a novel regulator of acinar differentiation using a variety of methodological strategies. NFIC binding sites are found at very short distances from NR5A2-bound genomic regions and both proteins co-occur in the same complex. Nfic knockout mice show reduced expression of acinar genes and, in ChIP-seq experiments, NFIC binds the promoters of acinar genes. In addition, NFIC binds to the promoter of, and regulates, genes involved in RNA and protein metabolism; in Nfic knockout mice, p-RS6K1 and p-IEF4E are down-regulated indicating reduced activity of the mTOR pathway. In 266-6 acinar cells, NFIC dampens the ER stress program through its binding to ER stress gene promoters and is required for complete resolution of Tunicamycin-mediated ER stress. Normal human pancreata from subjects with low NFIC mRNA levels display reduced epxression of genes down-regulated in Nfic knockout mice. Consistently, NFIC displays reduced expression upon induced acute pancreatitis and is required for proper recovery after damage. Finally, expression of NFIC is lower in samples of mouse and human pancreatic ductal adenocarcinoma and Nfic knockout mice develop an increased number of mutant Kras-driven pre-neoplastic lesions.

Summary (3 min read)

Jump to: [INTRODUCTION] – [Identification of novel transcription factors involved in the regulation of pancreatic] – [DISCUSSION] – [NFIC regulates expression of ribosomal genes and mitigates ER stress in the] – [NFIC is dynamically regulated during pancreatitis and cancer.] – [MATERIAL AND METHODS] – [Histology, immunofluorescence (IF) and immunohistochemical (IHC) analyses.] – [Quantitative RT-PCR (RT-qPCR).] – [Chromatin immunoprecipitation (ChIP).] and [Gene Set Enrichment Analysis (GSEA).]

INTRODUCTION

  • Pancreatic acinar cells are highly specialized protein synthesis factories that have a well-developed rough endoplasmic reticulum (ER), a prominent Golgi complex, and abundant secretory granules 1 .
  • Monoallelic or homozygous inactivation of several acinar transcriptional regulators in the germline, the embryonic pancreas, or the adult pancreas can result in compromised acinar function that favors loss of cellular identity and poises acinar cells for transformation upon activation of mutant KRas 10, 11, 12 .
  • Additional roles have been proposed through the regulation of Trp53 15, 16, 17 .
  • (which was not certified by peer review) is the author/funder.
  • Using a combination of omics analyses and studies in knockout mice and cultured cells, the authors now uncover novel roles of NFIC as a regulator of acinar function whose major impact is at the level of the ER stress response in murine and human pancreas.

Identification of novel transcription factors involved in the regulation of pancreatic

  • To discover novel transcription factors that might cooperate with known acinar regulators (e.g. PTF1A, GATA6, NR5A2, and MIST1), the authors reanalyzed publicly available ChIP-sequencing data and used HOMER to search for motifs enriched in the sequencing reads.
  • Motifs corresponding to RBPJ/RBPJL and HNF1, known regulators of acinar differentiation, were also enriched, thus validating the strategy applied.
  • Of all NFI family members, NFIC is expressed at highest levels in both mouse and human pancreas ; therefore, the authors focused on NFIC for further study.
  • Analysis of the published ChIP-Seq data revealed several PTF1A and NR5A2 peaks in the proximal Nfic promoter and the binding was confirmed by ChIP-qPCR , strongly suggesting that Nfic is a PTF1A and NR5A2 target.
  • The copyright holder for this preprint this version posted August 9, 2021.

DISCUSSION

  • Increasing evidence supports an "analog" differentiation model whereby additional TFs are required for "completion" of this process.
  • The conservation of spacing between NR5A2 and NFIC motifs among NR5A2 target genes supports transcriptional cooperation.
  • Comparison of NR5A2 ChIP-Seq data from embryonic and adult pancreas indicates that the role of NFIC is mainly in the latter, supporting its requirement for completion of acinar maturation and highlighting a functional role distinct from that of NR5A2.
  • NFI proteins were first proposed to be involved in the regulation of ubiquitous genes but they can also regulate tissue-specific genes 13 , including CEL in the mammary gland and DSPP in odontoblasts 14, 19 .
  • These findings suggest that the activation of pro-inflammatory phenotypes in mice in which acinar cells fail to acquire normal maturation can result from both direct (NR5A2 and GATA6) 4, 7, 10, 12 and indirect (PTF1A and NFIC) mechanisms, in agreement with the ChIP-Seq data available.

NFIC regulates expression of ribosomal genes and mitigates ER stress in the

  • Accordingly, a coordinated down-regulation of gene sets related to the digestive process and to protein metabolism and oxidative phosphorylation occurs in adult Nfic -/pancreata.
  • The mTOR pathway is a central actor in protein biosynthesis and autophagy and, therefore, a candidate mediator of this phenotype (reviewed in [33]).
  • The authors found reduced levels of P-RS6K1, its substrate P-RS6, and P-EIF4E, together with an up-regulation of P-ERK, in acinar cells of Nfic -/mice.
  • The finding that NFIC -but not NR5A2 -binds the promoter of ER stress genes suggests a distinct role of the former in this process.
  • A re-analysis of published data shows that Nfic is down-regulated in Nr5a2 -/hepatocytes in basal conditions (fold change of -0.54) 35 , suggesting that the deficient response to TM in Nr5a2 -/hepatocytes might partially occur through Nfic down-regulation.

NFIC is dynamically regulated during pancreatitis and cancer.

  • A failure to achieve complete acinar maturation is associated with more severe damage and delayed recovery during caerulein-mediated pancreatitis, as shown upon inactivation of Gata6, Mist1, and Ptf1a in the pancreas 4, 44 .
  • The role of NFIC in acinar cell differentiation and mitigation of ER stress suggested a contribution during tumorigenesis.
  • The copyright holder for this preprint this version posted August 9, 2021.
  • TFs previously described, the role of NFIC is restricted to the adult pancreas and distinctly affects RNA and protein metabolism and the UPR-mediated ER stress.

MATERIAL AND METHODS

  • All crosses were maintained in a predominant C57BL/6 background.
  • In brief, animals were weighed before the procedure and caerulein was administered intraperitoneally.
  • For the glucose tolerance test, male mice were fasted for 16 h and basal glycaemia was measured in tail blood.
  • For most experiments, >5 mice per group were used.

Histology, immunofluorescence (IF) and immunohistochemical (IHC) analyses.

  • Histological processing was performed using standard procedures.
  • After washing with PBS, sections were mounted with Prolong Gold Antifade Reagent (Life Technology).
  • Sections were incubated with 2% BSA-PBS for 1h at room temperature, and then with the primary antibody overnight at 4 ºC.
  • Briefly, areas of interest (AOI) were selected for quantification and then exported as individual TIFF images.
  • For quantification of KI67 + positive cells, at least 10 random images from each pancreas were selected and only positive acinar cells were quantified.

Quantitative RT-PCR (RT-qPCR).

  • Total RNA was treated with DNase I for 30 min at 37 °C and cDNAs were prepared according to the manufacturer's specifications, using the TaqMan reverse transcription reagents (Applied (which was not certified by peer review) is the author/funder.
  • For immunoprecipitation of proteins from fresh total pancreas lysates, a piece of mouse pancreas was isolated and minced in 50 mM Tris-HCl pH 8, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40 containing 3× phosphatase inhibitor cocktail (Sigma-Aldrich) and 3× EDTA-free complete protease inhibitor cocktail .
  • Afterwards, beads were washed three times with coupling buffer and once with 1 M Tris pH 9.
  • Protein lysates (10-15 mg, tissues) were then incubated overnight at 4 °C with antibody-coated dynabeads (Thermo Fisher Scientific).

Chromatin immunoprecipitation (ChIP).

  • Pancreas tissue was minced, washed with cold PBS supplemented with 3× protease and phosphatase cocktail inhibitors, and then fixed with 1% formaldehyde for 20 min at room temperature.
  • The supernatant was collected after centrifugation and chromatin was sonicated with a Covaris instrument for 40 min (20% duty cycle; 10% intensity; 200 cycle), yielding DNA fragments with a bulk size of 300-500 bp.
  • Data were analysed using the nextpresso pipeline http://bioinfo.cnio.es/nextpresso/).

Gene Set Enrichment Analysis (GSEA).

  • A ranking metric [-log10(p value)/sign(log2FoldChange)] was used to generate a ranked gene list from the DEseq output.
  • The resulting libraries were sequenced on Illumina HiSeq 2500, v4 Chemistry.
  • The copyright holder for this preprint this version posted August 9, 2021.
  • Among the two replicates, the one with highest number of identified target genes was taken: replicate 1 of NFIC ChIP-Seq in GM12878, NFIC ChIP-Seq in HepG2 and NFIC ChIP-Seq in SK-N-SH and replicate 2 of NFIC ChIP-Seq in ECC1 cell line.

Did you find this useful? Give us your feedback

Figures (1)

Content maybe subject to copyright    Report

NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells
1
and suppresses PDAC initiation
2
3
4
Isidoro Cobo,
1,2
Sumit Paliwal,
1
Júlia Melià-Alomà,
1,3
Ariadna Torres,
1,3
5
Jaime Martínez-Villarreal,
1
Fernando García,
4
Irene Millán,
1,2
Natalia del Pozo,
1,2
Joo-
6
Cheol Park,
5
Ray J. MacDonald,
6
Javier Muñoz,
4
and Francisco X. Real
1-3
7
8
9
Short title: NFIC in pancreatic homeostasis and cancer
10
11
1
Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO,
12
Madrid, Spain
13
2
CIBERONC, Madrid, Spain
14
3
Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra,
15
Barcelona, Spain
16
4
Proteomics Unit, Spanish National Cancer Research Centre-CNIO, Madrid, Spain.
17
ProteoRed - ISCIII
18
5
Department of Oral Histology-Developmental Biology, School of Dentistry, Seoul
19
National University, Seoul, Korea
20
6
Department of Molecular Biology, University of Texas Southwestern Medical Center,
21
Dallas, TX, USA
22
23
24
25
Correspondence: Francisco X. Real
26
Centro Nacional de Investigaciones Oncológicas-CNIO
27
Melchor Fernández Almagro, 3
28
28029-Madrid, Spain
29
E-mail: preal@cnio.es
30
31
32
Conflicts of interest: none to declare
33
34
35
Funding: This work was supported, in part, by grants SAF2011-29530, SAF2015-70553-
36
R, and RTI2018-101071-B-I00 from Ministerio de Ciencia, Innovación y Universidades
37
(Madrid, Spain) (co-funded by the ERDF-EU) and RTICC from Instituto de Salud Carlos
38
III (RD12/0036/0034) to FXR. IC was recipient of a Beca de Formación del Personal
39
Investigador from Ministerio de Economía y Competitividad (Madrid, Spain). The
40
research leading to these results has received funding from People Programme (Marie
41
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2021. ; https://doi.org/10.1101/2021.08.09.455477doi: bioRxiv preprint
2
Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007-
42
2013) (REA grant agreement n° 608765”). SP was supported by a Juan de la Cierva
43
Programme fellowship from Ministerio de Ciencia, Innovación y Universidades. IM was
44
supported by a Fellowship from Fundació Bancaria La Caixa (ID 100010434) (grant
45
number LCF/BQ/ES18/11670009). CNIO is supported by Ministerio de Ciencia,
46
Innovación y Universidades as a Centro de Excelencia Severo Ochoa SEV-2015-0510.
47
48
Statement of author contributions
49
IC: study concept and design; acquisition of data; analysis and interpretation of data;
50
statistical analysis; drafting of the manuscript;
51
SP: acquisition of data; analysis and interpretation of data; drafting of the manuscript
52
JMA: acquisition of data; analysis and interpretation of data; drafting of the manuscript
53
AT: acquisition of data; analysis and interpretation of data;
54
JMV: analysis and interpretation of data;
55
FG: acquisition of data; analysis and interpretation of data;
56
IM: analysis and interpretation of data;
57
NdP: technical support and acquisition of data;
58
JCP: material support;
59
RJM: critical revision of the data and important intellectual content;
60
JM: acquisition of data; analysis and interpretation of data;
61
FXR: study concept and design; analysis and interpretation of data; drafting of the
62
manuscript; overall study supervision; obtained funding.
63
All authors provided input about manuscript content.
64
Accession numbers: RNA sequencing data have been deposited in GEO with
65
accession number GSE126907 and NFIC ChIP sequencing data have been deposited
66
in GEO with accession number GSE181098
67
68
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2021. ; https://doi.org/10.1101/2021.08.09.455477doi: bioRxiv preprint
3
ABSTRACT
69
70
Tissue-specific differentiation is driven by specialized transcriptional networks.
71
Pancreatic acinar cells crucially rely on the PTF1 complex, and on additional
72
transcription factors, to deploy their transcriptional program. Here, we identify NFIC as a
73
novel regulator of acinar differentiation using a variety of methodological strategies. NFIC
74
binding sites are found at very short distances from NR5A2-bound genomic regions and
75
both proteins co-occur in the same complex. Nfic knockout mice show reduced
76
expression of acinar genes and, in ChIP-seq experiments, NFIC binds the promoters of
77
acinar genes. In addition, NFIC binds to the promoter of, and regulates, genes involved
78
in RNA and protein metabolism; in Nfic knockout mice, p-RS6K1 and p-IEF4E are down-
79
regulated indicating reduced activity of the mTOR pathway. In 266-6 acinar cells, NFIC
80
dampens the ER stress program through its binding to ER stress gene promoters and is
81
required for complete resolution of Tunicamycin-mediated ER stress. Normal human
82
pancreata from subjects with low NFIC mRNA levels display reduced epxression of
83
genes down-regulated in Nfic knockout mice. Consistently, NFIC displays reduced
84
expression upon induced acute pancreatitis and is required for proper recovery after
85
damage. Finally, expression of NFIC is lower in samples of mouse and human pancreatic
86
ductal adenocarcinoma and Nfic knockout mice develop an increased number of mutant
87
Kras-driven pre-neoplastic lesions.
88
89
Word count: 211
90
91
Keywords: NFIC, pancreas, acinar differentiation, ribosome, endoplasmic reticulum
92
stress, unfolded protein response, transcriptional networks, pancreatitis, pancreatic
93
cancer
94
95
Abbreviations: ChIP, chromatin immunoprecipitation; DEG, differentially expressed
96
genes; EMT, epithelial-mesenchymal transition; ER, endoplasmic reticulum; GSEA,
97
Gene set enrichment analysis; IF, immunofluorescence; IHC; immunohistochemistry;
98
PDAC, pancreatic ductal adenocarcinoma; TF, transcription factor; TM, tunicamycin;
99
UPR, unfolded protein response.
100
101
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2021. ; https://doi.org/10.1101/2021.08.09.455477doi: bioRxiv preprint
4
INTRODUCTION
102
103
Pancreatic acinar cells are highly specialized protein synthesis factories that
104
have a well-developed rough endoplasmic reticulum (ER), a prominent Golgi complex,
105
and abundant secretory granules
1
. Acinar differentiation is contingent on the activity of a
106
master regulator, the adult PTF1 complex, composed of the pancreas-specific
107
transcription factors (TFs) PTF1A and RPBJL and the ubiquitous protein E47
2,3
. PTF1
108
binds the proximal promoter of genes coding for digestive enzymes, secretory proteins
109
and other TFs, and activates their expression. The PTF1 complex is the main driver of
110
acinar differentiation but additional TF with tissue-restricted expression patterns are
111
implicated in the fine-tuning of this process, including GATA6
4
, MIST1
5
, and
112
NR5A2/LRH-1
6,7
. Acinar cells play a crucial role in acute and chronic pancreatitis, two
113
common and disabling conditions. Recent work using genetic mouse models has shown
114
that, upon expression of mutant KRas, acinar cells can be the precursors of Pancreatic
115
Intraepithelial Neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC)
8,9
.
116
Our laboratory and others have shown that the acinar differentiation program acts
117
as a tumor suppressor in the pancreas. Monoallelic or homozygous inactivation of
118
several acinar transcriptional regulators in the germline, the embryonic pancreas, or the
119
adult pancreas can result in compromised acinar function that favors loss of cellular
120
identity and poises acinar cells for transformation upon activation of mutant KRas
10,11,12
.
121
The tumor suppressive function of these TF is not obvious because the exocrine
122
pancreas has a large functional reserve, i.e. massive alterations in cellular function need
123
to occur in order to be reflected in histological or clinical changes.
124
Here, we use bioinformatics tools to identify NFIC as a novel acinar regulator.
125
NFIC is a member of the nuclear factor I family of TFs that regulate both ubiquitous and
126
tissue-restricted genes
13
. In the mammary gland, NFIC activates the expression of milk
127
genes involved in lactation
14
. Furthermore, it acts as a breast cancer tumor suppressor,
128
as it directly represses the expression of Ccnd1 and Foxf1, a potent inducer of epithelial-
129
mesenchymal transition (EMT), invasiveness, and tumorigenicity. Additional roles have
130
been proposed through the regulation of Trp53
15,16,17
. The physiological role of NFIC has
131
been best studied in dentinogenesis, since Nfic
-/-
mice develop short molar roots and
132
display aberrant odontoblast differentiation and dentin formation
18
. NFIC regulates
133
odontoblast-related genes, including Dssp
19
, Wnt
20
, and hedgehog signaling
21
.
134
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2021. ; https://doi.org/10.1101/2021.08.09.455477doi: bioRxiv preprint
5
Using a combination of omics analyses and studies in knockout mice and cultured
135
cells, we now uncover novel roles of NFIC as a regulator of acinar function whose major
136
impact is at the level of the ER stress response in murine and human pancreas. Unlike
137
most other TFs previously identified as required for full acinar function, NFIC belongs to
138
a novel family of acinar regulators with tissue-wide expression. NFIC dysregulation
139
sensitizes the pancreas to damage and neoplastic transformation.
140
141
142
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted August 9, 2021. ; https://doi.org/10.1101/2021.08.09.455477doi: bioRxiv preprint
Citations
More filters
Journal Article•DOI•
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma

[...]

Clare A. Rebbeck, Jian Xian, Susanne Bornelöv, Joseph Geradts, Amy Hobeika, Heather Geiger, Jose Franco Alvarez, Elena Rozhkova, Ashley Nicholls, Nicolas Robine, H. Kim Lyerly, Gregory J. Hannon 
13 Jun 2022-Nature Communications
TL;DR: In this article , gene expression analysis from 2,000 individually micro-dissected ductal lesions representing 145 patients was performed to identify early processes and potential biomarkers, including CAMK2N1 , MNX1 , ADCY5 , HOXC11 and ANKRD22 , whose reduced expression is associated with the progression of DCIS to invasive breast cancer.
Abstract: Abstract Ductal carcinoma in situ (DCIS) is considered a non-invasive precursor to breast cancer, and although associated with an increased risk of developing invasive disease, many women with DCIS will never progress beyond their in situ diagnosis. The path from normal duct to invasive ductal carcinoma (IDC) is not well understood, and efforts to do so are hampered by the substantial heterogeneity that exists between patients, and even within patients. Here we show gene expression analysis from > 2,000 individually micro-dissected ductal lesions representing 145 patients. Combining all samples into one continuous trajectory we show there is a progressive loss in basal layer integrity heading towards IDC, coupled with two epithelial to mesenchymal transitions, one early and a second coinciding with the convergence of DCIS and IDC expression profiles. We identify early processes and potential biomarkers, including CAMK2N1 , MNX1 , ADCY5 , HOXC11 and ANKRD22 , whose reduced expression is associated with the progression of DCIS to invasive breast cancer.

10 citations

Journal Article•DOI•
Transcriptome analysis of the response to thyroid hormone in Xenopus neural stem and progenitor cells

[...]

Camila Cordero-Véliz, Juan Larraín, Fernando Faunes
06 Sep 2022-Developmental Dynamics
TL;DR: This work provides new insights into the dynamics of activation of NPSCs in vivo in response to T3 during a critical period of neurogenesis in the metamorphosis, suggesting that NSPCs activation induced by T3 is characterized by an early proteome remodeling through the synthesis of the translation machinery and the degradation of proteins by the proteasome.
Abstract: The thyroid hormones—thyroxine (T4) and 3,5,3′triiodothyronine (T3)—regulate the development of the central nervous system (CNS) in vertebrates by acting in different cell types. Although several T3 target genes have been identified in the brain, the changes in the transcriptome in response to T3 specifically in neural stem and progenitor cells (NSPCs) during the early steps of NSPCs activation and neurogenesis have not been studied in vivo. Here, we characterized the transcriptome of FACS‐sorted NSPCs in response to T3 during Xenopus laevis metamorphosis.

2 citations

Posted Content•DOI•
Creating a ‘Timeline’ of ductal carcinoma in situ to identify processes and biomarkers for progression towards invasive ductal carcinoma

[...]

Clare A. Rebbeck, Jian Xian, Susanne Bornelöv, Joseph Geradts, Amy Hobeika, Heather Geiger, Jose Franco Alvarez, Elena Rozhkova, Ashley Nicholls, Nicolas Robine, H. Kim Lyerly, Gregory J. Hannon 
04 Mar 2022-bioRxiv
TL;DR: A ‘Timeline’ of disease progression is generated, utilising the variability within patients and combining >2,000 individually micro-dissected ductal lesions from 145 patients into one continuous trajectory, showing there is a progressive loss in basal layer integrity, coupled with two epithelial to mesenchymal transitions (EMT) early in the timeline.
Abstract: Ductal carcinoma in situ (DCIS) is considered a non-invasive precursor to breast cancer, and although associated with an increased risk of developing invasive disease, many women with DCIS will never progress beyond their in situ diagnosis. The path from normal duct to invasive disease is not well understood, and efforts to do so are hampered by the substantial heterogeneity that exists between patients and even within patients. Using gene expression analysis, we have generated a ‘Timeline’ of disease progression, utilising the variability within patients and combining >2,000 individually micro-dissected ductal lesions from 145 patients into one continuous trajectory. Using this Timeline we show there is a progressive loss in basal layer integrity, coupled with two epithelial to mesenchymal transitions (EMT), one early in the timeline and a second just prior to cells leaving the duct. We identify early processes and potential biomarkers, including CAMK2N1, MNX1, ADCY5, HOXC11 and ANKRD22, whose reduced expression is associated with the progression of DCIS to invasive breast cancer.
References
More filters
Journal Article•DOI•
Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation

[...]

Guido von Figura1, John P. Morris1, Christopher V.E. Wright2, Matthias Hebrok1•
University of California, San Francisco1, Vanderbilt University2
01 Apr 2014-Gut
TL;DR: It is shown that Nr5a2 is not required for the development of the pancreatic acinar lineage but is important for maintenance of acinar identity and re-establishing acinar fate during regeneration, providing functional evidence supporting a potential role as a susceptibility gene for human PDA.
Abstract: Objectives Emerging evidence from mouse models suggests that mutant Kras can drive the development of pancreatic ductal adenocarcinoma (PDA) precursors from acinar cells by enforcing ductal de-differentiation at the expense of acinar identity. Recently, human genome-wide association studies have identified NR5A2 , a key regulator of acinar function, as a susceptibility locus for human PDA. We investigated the role of Nr5a2 in exocrine maintenance, regeneration and Kras driven neoplasia. Design To investigate the function of Nr5a2 in the pancreas, we generated mice with conditional pancreatic Nr5a2 deletion ( PdxCre late ; Nr5a2 c/c ). Using this model, we evaluated acinar differentiation, regeneration after caerulein pancreatitis and Kras driven pancreatic neoplasia in the setting of Nr5a2 deletion. Results We show that Nr5a2 is not required for the development of the pancreatic acinar lineage but is important for maintenance of acinar identity. Nr5a2 deletion leads to destabilisation of the mature acinar differentiation state, acinar to ductal metaplasia and loss of regenerative capacity following acute caerulein pancreatitis. Loss of Nr5a2 also dramatically accelerates the development of oncogenic Kras driven acinar to ductal metaplasia and PDA precursor lesions. Conclusions Nr5a2 is a key regulator of acinar plasticity. It is required for maintenance of acinar identity and re-establishing acinar fate during regeneration. Nr5a2 also constrains pancreatic neoplasia driven by oncogenic Kras, providing functional evidence supporting a potential role as a susceptibility gene for human PDA.

130 citations

Journal Article•DOI•
The Role of PTF1-P48 in Pancreatic Acinar Gene Expression

[...]

Scott D. Rose1, Galvin H. Swift1, Michael Peyton1, Robert E. Hammer1, Raymond J. MacDonald1 •
University of Texas Southwestern Medical Center1
23 Nov 2001-Journal of Biological Chemistry
TL;DR: Comparison of the 5′-gene flanking regions of the mouse, rat, and human genes identified conserved sequence blocks containing binding sites for known gut transcription factors within the acinar cell-specific control region.

118 citations

Journal Article•DOI•
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

[...]

Ekaterina Semenova1, Minchul Kwon1, Kim Monkhorst1, Ji-Ying Song1, Rajith Bhaskaran1, Oscar Krijgsman1, Thomas Kuilman1, Dennis Peters1, Wieneke A. Buikhuisen1, Egbert F. Smit1, Colin Pritchard1, Miranda Cozijnsen1, Jan van der Vliet1, John Zevenhoven1, Jan-Paul Lambooij1, Natalie Proost1, Erwin van Montfort1, Arno Velds1, Ivo J. Huijbers1, Anton Berns2, Anton Berns1 •
Netherlands Cancer Institute1, Skolkovo Institute of Science and Technology2
19 Jul 2016-Cell Reports
TL;DR: It is reported that, although overexpression of either transcription factor accelerates tumor growth, NFIB specifically promotes metastatic spread and is overexpressed in almost all tested human metastatic high-grade neuroendocrine lung tumors.

109 citations

Journal Article•DOI•
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

[...]

Daniele Biasci1, Martin Smoragiewicz1, Claire M. Connell1, Claire M. Connell2, Zhikai Wang3, Ya Gao3, James Thaventhiran1, Bristi Basu2, Bristi Basu1, Lukasz Magiera1, T. Isaac Johnson1, Lisa Bax2, Aarthi Gopinathan1, Christopher Isherwood1, Ferdia A. Gallagher2, Maria Pawula1, Irena Hudecova1, Davina Gale1, Nitzan Rosenfeld1, Petros Barmpounakis4, Elizabeta C. Popa5, Rebecca Brais2, Edmund Godfrey2, Fraz Mir1, Frances M. Richards1, Douglas T. Fearon1, Douglas T. Fearon5, Douglas T. Fearon3, Tobias Janowitz, Duncan I. Jodrell1 •
University of Cambridge1, Cambridge University Hospitals NHS Foundation Trust2, Cold Spring Harbor Laboratory3, Athens University of Economics and Business4, Cornell University5
17 Nov 2020-Proceedings of the National Academy of Sciences of the United States of America
TL;DR: In this article, the authors showed that CXCL12-stimulated CXCR4 inhibits the directed migration mediated by all of the immune cell types that participate in an integrated immune response.
Abstract: Inhibition of the chemokine receptor CXCR4 in combination with blockade of the PD-1/PD-L1 T cell checkpoint induces T cell infiltration and anticancer responses in murine and human pancreatic cancer. Here we elucidate the mechanism by which CXCR4 inhibition affects the tumor immune microenvironment. In human immune cell-based chemotaxis assays, we find that CXCL12-stimulated CXCR4 inhibits the directed migration mediated by CXCR1, CXCR3, CXCR5, CXCR6, and CCR2, respectively, chemokine receptors expressed by all of the immune cell types that participate in an integrated immune response. Inhibiting CXCR4 in an experimental cancer medicine study by 1-wk continuous infusion of the small-molecule inhibitor AMD3100 (plerixafor) induces an integrated immune response that is detected by transcriptional analysis of paired biopsies of metastases from patients with microsatellite stable colorectal and pancreatic cancer. This integrated immune response occurs in three other examples of immune-mediated damage to noninfected tissues: Rejecting renal allografts, melanomas clinically responding to anti-PD1 antibody therapy, and microsatellite instable colorectal cancers. Thus, signaling by CXCR4 causes immune suppression in human pancreatic ductal adenocarcinoma and colorectal cancer by impairing the function of the chemokine receptors that mediate the intratumoral accumulation of immune cells.

109 citations

Journal Article•DOI•
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells

[...]

Eileen L. Heinrich1, Wendy Lee1, Jianming Lu1, Andrew M. Lowy2, Joseph Kim1 •
City of Hope National Medical Center1, University of California, San Diego2
02 Apr 2012-Journal of Translational Medicine
TL;DR: The data demonstrate that CXCR4 and CX CR7 are frequently co-expressed in human pancreatic cancer tissues and cell lines and show that β-arrestin-2 and K-Ras dependent pathways coordinate the transduction of CXCL12 signals.
Abstract: Previously assumed to be a select ligand for chemokine receptor CXCR4, chemokine CXCL12 is now known to activate both CXCR4 and CXCR7. However, very little is known about the co-expression of these receptors in cancer cells. We used immunohistochemistry to determine the extent of co-expression in pancreatic cancer tissue samples and immunoblotting to verify expression in pancreatic cancer cell lines. In cell culture studies, siRNA was used to knock down expression of CXCR4, CXCR7, K-Ras and β-arrestin -2 prior to stimulating the cells with CXCL12. Activation of the mitogen-activated protein kinase pathway (MAPK) was assessed using both a Raf-pull down assay and western blotting. The involvement of the receptors in CXCL12-mediated increases in cell proliferation was examined via an ATP-based proliferation assay. First, we discovered frequent CXCR4/CXCR7 co-expression in human pancreatic cancer tissues and cell lines. Next, we observed consistent increases in ERK1/2 phosphorylation after exposure to CXCL12 or CXCL11, a CXCR7 agonist, in pancreatic cancer cell lines co-expressing CXCR4/CXCR7. To better characterize the receptor-mediated pathway(s), we knocked down CXCR4 or CXCR7, exposed the cells to CXCL12 and examined subsequent effects on ERK1/2. We observed that CXCR7 mediates the CXCL12-driven increase in ERK1/2 phosphorylation. Knockdown of CXCR4 expression however, decreased levels of K-Ras activity. Conversely, KRAS knockdown greatly reduced CXCL12-mediated increases in ERK1/2 phosphorylation. We then evaluated the role of β-arrestin-2, a protein directly recruited by chemokine receptors. We observed that β-arrestin-2 knockdown also inhibited increases in ERK1/2 phosphorylation mediated by both CXCR4 and CXCR7. Finally, we investigated the mechanism for CXCL12-enhanced cell proliferation and found that either receptor can modulate cell proliferation. In summary, our data demonstrate that CXCR4 and CXCR7 are frequently co-expressed in human pancreatic cancer tissues and cell lines. We show that β-arrestin-2 and K-Ras dependent pathways coordinate the transduction of CXCL12 signals. Our results suggest that the development of therapies based on inhibiting CXCL12 signaling to halt the growth of pancreatic cancer should be focused at the ligand level in order to account for the contributions of both receptors to this signaling pathway.

105 citations

Related Papers (5)
Overexpression of Transcription Factor Sp1 Leads to Gene Expression Perturbations and Cell Cycle Inhibition

[...]

15 Sep 2009-PLOS ONE
Emmanuelle Deniaud, Joël Baguet, Roxane Chalard, Roxane Chalard, Bariza Blanquier, Lilia Brinza, Julien Meunier, Julien Meunier, Marie-Cécile Michallet, Aurélie Laugraud, Claudette Ah-Soon, Anne Wierinckx, Marc Castellazzi, Joël Lachuer, Christian Gautier, Jacqueline Marvel, Yann Leverrier 
Hepatocyte nuclear factor 1α and β control terminal differentiation and cell fate commitment in the gut epithelium

[...]

01 May 2010-Development
Anna D'Angelo, Olivier Bluteau, Miguel A. Garcia-Gonzalez, Lionel Gresh, Antonia Doyen, Serge Garbay, Sylvie Robine, Marco Pontoglio 
p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability.

[...]

01 Jul 2012-Molecular and Cellular Biology
Wensheng Yan, Jin Zhang, Yanhong Zhang, Yong Sam Jung, Xinbin Chen 
Pax6 Controls the Expression of Critical Genes Involved in Pancreatic α Cell Differentiation and Function

[...]

22 Oct 2010-Journal of Biological Chemistry
Yvan Gosmain, Eric Marthinet, Claire Cheyssac, Audrey Guérardel, Aline Mamin, Liora S. Katz, Karim Bouzakri, Jacques Philippe 
Transcription factor TEAD4 regulates expression of myogenin and the unfolded protein response genes during C2C12 cell differentiation.

[...]

01 Feb 2012-Cell Death & Differentiation
A Benhaddou, Céline Keime, Tao Ye, A Morlon, Isabelle Michel, Bernard Jost, Gabrielle Mengus, Irwin Davidson